表紙
市場調查報告書

生物武器防禦的全球市場:產品,及各地區 - 市場分析,佔有率,趨勢,規模,及預測(2019年∼2025年)

Biodefense Market, By Product (Smallpox, Anthrax, Radiation/Nuclear, Botulism, Detectors/Triggering Devices, Samplers, Identifiers, Assays, & Reagents), & Geography-Analysis, Share, Trends, Size, & Forecast from 2019-2025

出版商 AnalystView Market Insights 商品編碼 918917
出版日期 內容資訊 英文 159 Pages
商品交期: 2-3個工作天內
價格
Back to Top
生物武器防禦的全球市場:產品,及各地區 - 市場分析,佔有率,趨勢,規模,及預測(2019年∼2025年) Biodefense Market, By Product (Smallpox, Anthrax, Radiation/Nuclear, Botulism, Detectors/Triggering Devices, Samplers, Identifiers, Assays, & Reagents), & Geography-Analysis, Share, Trends, Size, & Forecast from 2019-2025
出版日期: 2019年12月01日內容資訊: 英文 159 Pages
簡介

全球生物武器防禦市場在2018年估算為54億2,000萬美金。該市場在2019年∼2025年間,預測將以4.8%的年複合成長率成長。政府致力解決生物威脅,是推動該市場的成長的要素。

本報告提供全球生物武器防禦市場的相關調查,提供市場機會和趨勢,成長及阻礙因素,各產品·地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 市場概要

  • 調查範圍
  • 前提條件

第2章 摘要整理

  • 市場區隔
    • 各產品
    • 各地區
  • 競爭情形

第3章 主要市場趨勢

  • 市場成長要素
    • 影響分析
  • 市場阻礙因素
    • 影響分析
  • 市場機會
  • 市場今後趨勢

第4章 產業調查

  • 波特的五力分析
  • 行銷策略分析
  • 成長預測的製圖
  • 法律規範分析

第5章 市場情況

  • 市場佔有率分析
  • 主要的創新者
  • 各主要製造商:明細資料
    • 現有企業分析
    • 新興企業分析

第6章 市場分析:各產品

  • 概要
    • 市場區隔佔有率分析
  • 疫苗
    • 概要
    • 市場分析,預測,與前一年同期比較成長率
    • 天花
    • 炭疽病
    • 放射線/核
    • 肉毒桿菌中毒
  • 生物威脅檢測設備
    • 概要
    • 市場分析,預測,與前一年同期比較成長率
    • 採樣器
    • 鑑別器
    • 化驗
    • 試劑
    • 檢測器/觸發器設備

第7章 市場分析:各地區

  • 簡介
    • 市場區隔佔有率分析
  • 北美
    • 概要
    • 主要製造商
    • 市場規模·預測:各國
    • 市場規模·預測:各產品
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 義大利
    • 英國
    • 法國
    • 其他
  • 亞太地區(APAC)
    • 印度
    • 中國
    • 日本
    • 韓國
    • 其他
  • 南美
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他
  • 中東·非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第8章 主要供應商分析

  • Dynavax Technologies
    • 企業簡介
    • 財務實際成果
    • 產品的基準
    • 策略性配合措施
  • Xoma Corporation
  • Emergent BioSolutions, Inc.
  • SIGA Technologies, Inc.
  • PharmAthene, Inc.
  • Elusys Therapeutics, Inc.
  • Dynport Vaccine Company
  • Bavarian Nordic
  • Ichor Medical Systems
  • Cleveland Biolabs
  • Nanotherapeutics, Inc.
  • Achaogen, Inc.
  • Alnylam Pharmaceuticals, Inc.

第9章 關於ANALYSTVIEW

第10章 附錄

  • 調查方法
  • 參照資料
  • 簡稱
  • 免責聲明
  • 諮詢方式

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

REPORT HIGHLIGHT

Biodefense Market was valued at USD 5.42 billion by 2018, growing with 4.8% CAGR during the forecast period, 2019-2025

MARKET DYNAMICS

Biodefense is defined as the actions designed to counter biological threats, and prepare to respond bio-incidents. It also refers to the short term, usually military measures to restore biosecurity. Biodefense constitutes the use of medical measures in order to protect individuals against bioterrorism. Biodefense applied to two distinct target populations that are military combatant (troops in the field), and civilian non-combatant.

The market growth is majorly driven by favorable government initiatives. Organizations such as Centers for Disease Control and Prevention (CDC), the Department of Defense (DoD), Biomedical Advanced Research and Development Authority (BARDA), and the United States Department of Health & Human Services (HHS) are actively working towards medical countermeasures against such biological threats. Such initiatives would, in turn, support the market growth to a great extent. However, strict regulations coupled with high barriers to entry will hamper the market growth to some extent.

PRODUCT TAKEAWAY

The product segment is broadly classified into vaccines and biothreat detection devices. Vaccine products are further divided into Smallpox, Anthrax, Radiation/nuclear, Botulism, and others. Anthrax and smallpox are amongst the key areas for R&D activities due to their high potential for destruction. These products are continuing to command the attention of many governments globally, accounting for a significant share of the worldwide market. Of these, anthrax captured the highest revenue share, i.e. over 30% in 2018 owing to the rising investments by the U.S. government for mitigating the anthrax bioterrorism risk. Currently, Anthrax Vaccine Adsorbed (AVA) is the only U.S. FDA licensed anthrax vaccine, commercially available under BioThrax trade name in the U.S. market.

Whereas, biothreat detection devices segment is categorized into detectors/triggering devices, samplers, identifiers, assays, and reagents. Biodefense samplers are primarily used to facilitate biological sampling as well as for the transport packaging, reducing waste and speeding up sampling time.

REGIONAL TAKEAWAY

North America captured the highest share (more than 70%) of the worldwide biodefense market. Rising financial support by the U.S. military and civilian agencies for R&D activities coupled with favorable government policies support the regional growth. For instance, the U.S. government has taken steps to implement an enterprise approach and integrated strategy to combat biological threats. In September 2018. U.S. President Donald J. Trump has suggested implementing a National Biodefense Strategy to effectively prepare for fighting biological threats.

On the other side, developing regions such as the Asia Pacific accounts for significant revenue share. Regional growth is majorly attributed to the rising government support coupled with the growing number of conferences on biosafety. For instance, in September 2019, Asia Pacific Biosafety Association (A-PBA) has organized the 14th Annual Biorisk Conference in Dhaka, Bangladesh. This conference was aimed to discuss proactive steps on biosafety and biosecurity for the sustainable development of a region in the healthcare and agricultural sectors.

KEY VENDORS TAKEAWAY

Key players operating in the global biodefense market include Achaogen, Inc., Xoma Corporation, Emergent BioSolutions, Inc., SIGA Technologies, Inc., PharmAthene, Inc., Elusys Therapeutics, Inc., Dynavax Technologies, Ichor Medical Systems, Cleveland Biolabs, Dynport Vaccine Company, Nanotherapeutics, Inc., Bavarian Nordic, and Alnylam Pharmaceuticals, Inc.

Companies are actively engaged in mergers and acquisitions to expand their presence in the biodefense industry. For instance, a biopharmaceutical company, "Altimmune" acquired PharmAthene, Inc., a biodefense firm in May 2017. This collaboration is aimed to create a new immunotherapy company focused on developing products for infectious diseases such as anthrax. Such activities would, in turn, help key players to expand their presence in this industry.

The market size and forecast for each segment and sub-segments has been considered as below:

  • Historical Year - 2014 & 2016
  • Base Year - 2017
  • Estimated Year - 2018
  • Projected Year - 2025

TARGET AUDIENCE

  • Traders, Distributors, and Suppliers
  • Manufacturers
  • Government and Regional Agencies
  • Research Organizations
  • Consultants
  • Distributors

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

KEY PLAYERS

  • Dynavax Technologies
  • Xoma Corporation
  • Emergent BioSolutions, Inc.
  • SIGA Technologies, Inc.
  • PharmAthene, Inc.
  • Elusys Therapeutics, Inc.
  • Dynport Vaccine Company
  • Bavarian Nordic
  • Ichor Medical Systems
  • Cleveland Biolabs
  • Nanotherapeutics, Inc.
  • Achaogen, Inc.
  • Alnylam Pharmaceuticals, Inc.

MARKET, BY PRODUCT

  • Vaccines
  • Smallpox
  • Anthrax
  • Radiation/Nuclear
  • Botulism
  • Biothreat Detection Devices
  • Samplers
  • Identifiers
  • Assays
  • Reagents
  • Detectors/Triggering Devices

MARKET, BY REGION

  • North America
  • S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Singapore
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of LATAM
  • Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Rest of MEA

TABLE OF CONTENT

1.BIODEFENSE MARKET OVERVIEW

  • 1.1.Study Scope
  • 1.2.Assumption and Methodology

2.EXECUTIVE SUMMARY

  • 2.1.Market Snippet
    • 2.1.1.Market Snippet by Product
    • 2.1.2.Market Snippet by Region
  • 2.2.Competitive Insights

3.BIODEFENSE KEY MARKET TRENDS

  • 3.1.Market Drivers
    • 3.1.1.Impact Analysis of Market Drivers
  • 3.2.Market Restraints
    • 3.2.1.Impact Analysis of Market Restraints
  • 3.3.Market Opportunities
  • 3.4.Market Future Trends

4.BIODEFENSE INDUSTRY STUDY

  • 4.1.Porter's Five Forces Analysis
  • 4.2.Marketing Strategy Analysis
  • 4.3.Growth Prospect Mapping
  • 4.4.Regulatory Framework Analysis

5.BIODEFENSE MARKET LANDSCAPE

  • 5.1.Market Share Analysis
  • 5.2.Key Innovators
  • 5.3.Breakdown Data, by Key manufacturer
    • 5.3.1.Established Player Analysis
    • 5.3.2.Emerging Player Analysis

6.BIODEFENSE MARKET - BY PRODUCT

  • 6.1.Overview
    • 6.1.1.Segment Share Analysis, By Product, 2018 & 2025 (%)
  • 6.2.Vaccines
    • 6.2.1.Overview
    • 6.2.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
    • 6.2.3.Smallpox
      • 6.2.3.1.Overview
      • 6.2.3.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
    • 6.2.4.Anthrax
      • 6.2.4.1.Overview
      • 6.2.4.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
    • 6.2.5.Radiation/Nuclear
      • 6.2.5.1.Overview
      • 6.2.5.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
    • 6.2.6.Botulism
      • 6.2.6.1.Overview
      • 6.2.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
  • 6.3.Biothreat Detection Devices
    • 6.3.1.Overview
    • 6.3.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
    • 6.3.3.Samplers
      • 6.3.3.1.Overview
      • 6.3.3.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
    • 6.3.4.Identifiers
      • 6.3.4.1.Overview
      • 6.3.4.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
    • 6.3.5.Assays
      • 6.3.5.1.Overview
      • 6.3.5.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
    • 6.3.6.Reagents
      • 6.3.6.1.Overview
      • 6.3.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
    • 6.3.7.Detectors/Triggering Devices
      • 6.3.7.1.Overview
      • 6.3.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)

7.BIODEFENSE MARKET- BY GEOGRAPHY

  • 7.1.Introduction
    • 7.1.1.Segment Share Analysis, By Region, 2018 & 2025 (%)
  • 7.2.North America
    • 7.2.1.Overview
    • 7.2.2.Key Manufacturers in North America
    • 7.2.3.North America Market Size and Forecast, By Country, 2014 - 2025 (US$ Million)
    • 7.2.4.North America Market Size and Forecast, By Product, 2014 - 2025 (US$ Million)
    • 7.2.5.U.S.
      • 7.2.5.1.Overview
      • 7.2.5.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
    • 7.2.6.Canada
      • 7.2.6.1.Overview
      • 7.2.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
  • 7.3.Europe
    • 7.3.1.Overview
    • 7.3.2.Key Manufacturers in Europe
    • 7.3.3.Europe Market Size and Forecast, By Country, 2014 - 2025 (US$ Million)
    • 7.3.4.Europe Market Size and Forecast, By Product, 2014 - 2025 (US$ Million)
    • 7.3.5.Germany
      • 7.3.5.1.Overview
      • 7.3.5.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
    • 7.3.6.Italy
      • 7.3.6.1.Overview
      • 7.3.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
    • 7.3.7.United Kingdom
      • 7.3.7.1.Overview
      • 7.3.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
    • 7.3.8.France
      • 7.3.8.1.Overview
      • 7.3.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
    • 7.3.9.Rest of Europe
      • 7.3.9.1.Overview
      • 7.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
  • 7.4.Asia Pacific (APAC)
    • 7.4.1.Overview
    • 7.4.2.Key Manufacturers in Asia Pacific
    • 7.4.3.Asia Pacific Market Size and Forecast, By Country, 2014 - 2025 (US$ Million)
    • 7.4.4.Asia Pacific Market Size and Forecast, By Product, 2014 - 2025 (US$ Million)
    • 7.4.5.India
      • 7.4.5.1.Overview
      • 7.4.5.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
    • 7.4.6.China
      • 7.4.6.1.Overview
      • 7.4.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
    • 7.4.7.Japan
      • 7.4.7.1.Overview
      • 7.4.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
    • 7.4.8.South Korea
      • 7.4.8.1.Overview
      • 7.4.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
    • 7.4.9.Rest of APAC
      • 7.4.9.1.Overview
      • 7.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
  • 7.5.Latin America
    • 7.5.1.Overview
    • 7.5.2.Key Manufacturers in Latin America
    • 7.5.3.Latin America Market Size and Forecast, By Country, 2014 - 2025 (US$ Million)
    • 7.5.4.Latin America Market Size and Forecast, By Product, 2014 - 2025 (US$ Million)
    • 7.5.5.Brazil
      • 7.5.5.1.Overview
      • 7.5.5.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
    • 7.5.6.Mexico
      • 7.5.6.1.Overview
      • 7.5.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
    • 7.5.7.Argentina
      • 7.5.7.1.Overview
      • 7.5.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
    • 7.5.8.Rest of LATAM
      • 7.5.8.1.Overview
      • 7.5.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
  • 7.6.Middle East and Africa
    • 7.6.1.Overview
    • 7.6.2.Key Manufacturers in Middle East and Africa
    • 7.6.3.Middle East and Africa Market Size and Forecast, By Country, 2014 - 2025 (US$ Million)
    • 7.6.4.Middle East and Africa Market Size and Forecast, By Product, 2014 - 2025 (US$ Million)
    • 7.6.5.Saudi Arabia
      • 7.6.5.1.Overview
      • 7.6.5.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)
    • 7.6.6.United Arab Emirates
      • 7.6.6.1.Overview
      • 7.6.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 - 2025, (US$ Million)

8.KEY VENDOR ANALYSIS

  • 8.1.Dynavax Technologies
    • 8.1.1.Company Snapshot
    • 8.1.2.Financial Performance
    • 8.1.3.Product Benchmarking
    • 8.1.4.Strategic Initiatives
  • 8.2.Xoma Corporation
  • 8.3.Emergent BioSolutions, Inc.
  • 8.4.SIGA Technologies, Inc.
  • 8.5.PharmAthene, Inc.
  • 8.6.Elusys Therapeutics, Inc.
  • 8.7.Dynport Vaccine Company
  • 8.8.Bavarian Nordic
  • 8.9.Ichor Medical Systems
  • 8.10.Cleveland Biolabs
  • 8.11.Nanotherapeutics, Inc.
  • 8.12.Achaogen, Inc.
  • 8.13.Alnylam Pharmaceuticals, Inc.

9.360 DEGREE ANALYSTVIEW

10.APPENDIX

  • 10.1.Research Methodology
  • 10.2.References
  • 10.3.Abbreviations
  • 10.4.Disclaimer
  • 10.5.Contact Us

List of Figures

  • FIGURE Biodefense market segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE Competitive Landscape; Key company market share analysis, 2018
  • FIGURE Product segment market share analysis, 2018 & 2025
  • FIGURE Product segment market size forecast and trend analysis, 2014 to 2025 (USD Million)
  • FIGURE Vaccines market size forecast and trend analysis, 2014 to 2025 (USD Million)
  • FIGURE Smallpox market size forecast and trend analysis, 2014 to 2025 (USD Million)
  • FIGURE Anthrax market size forecast and trend analysis, 2014 to 2025 (USD Million)
  • FIGURE Radiation/Nuclear market size forecast and trend analysis, 2014 to 2025 (USD Million)
  • FIGURE Botulism market size forecast and trend analysis, 2014 to 2025 (USD Million)
  • FIGURE Biothreat Detection Devices market size forecast and trend analysis, 2014 to 2025 (USD Million)
  • FIGURE Samplers market size forecast and trend analysis, 2014 to 2025 (USD Million)
  • FIGURE Identifiers market size forecast and trend analysis, 2014 to 2025 (USD Million)
  • FIGURE Assays market size forecast and trend analysis, 2014 to 2025 (USD Million)
  • FIGURE Reagents market size forecast and trend analysis, 2014 to 2025 (USD Million)
  • FIGURE Detectors/Triggering Devices market size forecast and trend analysis, 2014 to 2025 (USD Million)
  • FIGURE Regional segment market share analysis, 2018 & 2025
  • FIGURE Regional segment market size forecast and trend analysis, 2014 to 2025 (USD Million)
  • FIGURE North America Biodefense market share and leading players, 2018
  • FIGURE Europe Biodefense market share and leading players, 2018
  • FIGURE Asia Pacific Biodefense market share and leading players, 2018
  • FIGURE Latin America Biodefense market share and leading players, 2018
  • FIGURE Middle East and Africa Biodefense market share and leading players, 2018
  • FIGURE North America market share analysis by country, 2018
  • FIGURE U.S. market size, forecast and trend analysis, 2014 to 2025 (USD Million)
  • FIGURE Canada market size, forecast and trend analysis, 2014 to 2025 (USD Million)
  • FIGURE Europe market share analysis by country, 2018
  • FIGURE Germany market size, forecast and trend analysis, 2014 to 2025 (USD Million)
  • FIGURE Spain market size, forecast and trend analysis, 2014 to 2025 (USD Million)
  • FIGURE Italy market size, forecast and trend analysis, 2014 to 2025 (USD Million)
  • FIGURE UK market size, forecast and trend analysis, 2014 to 2025 (USD Million)
  • FIGURE France market size, forecast and trend analysis, 2014 to 2025 (USD Million)
  • FIGURE Rest of the Europe market size, forecast and trend analysis, 2014 to 2025 (USD Million)
  • FIGURE Asia Pacific market share analysis by country, 2018
  • FIGURE India market size, forecast and trend analysis, 2014 to 2025 (USD Million)
  • FIGURE China market size, forecast and trend analysis, 2014 to 2025 (USD Million)
  • FIGURE Japan market size, forecast and trend analysis, 2014 to 2025 (USD Million)
  • FIGURE South Korea market size, forecast and trend analysis, 2014 to 2025 (USD Million)
  • FIGURE Singapore market size, forecast and trend analysis, 2014 to 2025 (USD Million)
  • FIGURE Rest of APAC market size, forecast and trend analysis, 2014 to 2025 (USD Million)
  • FIGURE Latin America market size, forecast and trend analysis, 2014 to 2025 (USD Million)
  • FIGURE Latin America market share analysis by country, 2018
  • FIGURE Brazil market size, forecast and trend analysis, 2014 to 2025 (USD Million)
  • FIGURE Mexico market size, forecast and trend analysis, 2014 to 2025 (USD Million)
  • FIGURE Argentina market size, forecast and trend analysis, 2014 to 2025 (USD Million)
  • FIGURE Rest of LATAM market size, forecast and trend analysis, 2014 to 2025 (USD Million)
  • FIGURE Middle East and Africa market size, forecast and trend analysis, 2014 to 2025 (USD Million)
  • FIGURE Middle East and Africa market share analysis by country, 2018
  • FIGURE Saudi Arabia market size, forecast and trend analysis, 2014 to 2025 (USD Million)
  • FIGURE United Arab Emirates market size, forecast and trend analysis, 2014 to 2025 (USD Million)
Back to Top